Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ukusheshisa Ukulungiswa Kwamaseli E-CAR-T Ukuze Kuthuthukiswe Imiphumela Yesiguli

2024-11-14

Ukwelashwa ngamaseli e-CAR-T, ukwelashwa okusha kwe- I-B-Cell Leukemia kanye ne-lymphoma, kuhlolwa kabanzi eminye imidlavuza yegazi, izimila eziqinile, kanye nezinkinga zokuzivikela komzimba. Kodwa-ke, ukwandisa lokhu kwelashwa kube yizinkomba ezintsha kuveza izinselele zezokuthutha, njengoba ukukhiqizwa kwamanje kwamaseli e-CAR-T kungathatha amasonto ama-3-6. Ukubuyekezwa kwamuva ku-I-Lancet Haematology ixoxa ngentuthuko ebalulekile ekukhiqizweni kwamaseli e-CAR-T okuhlose ukwenza lula izinqubo, ukuthuthukisa ikhwalithi yamaseli, kanye nokwandisa ukufinyeleleka kweziguli.

11.14(2).webp

 

Ngokwesiko, ukulungiswa kwamaseli e-CAR-T kudinga ukuvuselelwa nokwandiswa okukhulu kwamaseli e-in vitro, okungaholela ekukhathaleni kwamaseli kanye nokuncipha kokusebenza kahle kokwelapha. Izinto ezintsha zakamuva, njengezinqubo zokwandiswa okuncishisiwe, izindlela zokungasebenzisi, kanye nokukhiqizwa kwendawo yokunakekelwa, kunikeza ushintsho olusheshayo ngokulawulwa okuncane kwe-in vitro. Lezi zindlela, manje sezisetshenziswa kokubili ezivivinyweni zemitholampilo kanye nakwezentengiselwano. Imikhiqizo ye-CAR-T, kugcizelela ukukhiqizwa kwamaseli e-CAR-T angahlukanisiwe kakhulu futhi angakhathali, okuholela ekwelashweni okungase kuhlinzeke ngemiphumela yokulwa nomdlavuza eqhubekayo.

 

Ukubuyekezwa kuphinde kugqamise inqubekela phambili ekukhethweni kwangaphambili kwamaseli e-T ukuze kususwe amaseli angafuneki noma acindezela amasosha omzimba, okuthuthukisa amandla okwelapha emikhiqizo ye-CAR-T. Ama-algorithms athuthukisa isikhathi se-leukapheresis ngokusekelwe emiphumeleni yegazi yangaphambi kokwelashwa athuthukisa ukusebenza kahle kwemithombo kanye nokufinyeleleka kwayo.

 

Izinqubo zokulungiselela i-CAR-T ezisheshayo sezivele zibonisa imiphumela ethembisayo. Izivivinyo zemitholampilo zibonisa ukuthi izikhathi zokukhiqiza ezimfushane zingaholela ekuqineni nasekusebenzeni kahle kwamaseli, ngezifundo eziqhubekayo ezihlola amasu okukhiqiza ashesha kakhulu aletha amaseli e-CAR-T ezigulini ngosuku olulodwa.

 

Ngaphezu kwezindlela zokunciphisa ukwanda, ubunjiniyela bamaseli obusha bukhulisa ukusebenza kahle kwe-CAR-T. Amasu afaka phakathi ukusetshenziswa kwama-molecule inhibitors amancane ngesikhathi sokukhiqiza ukuze kulondolozwe izinhlobo zememori yamaseli e-T futhi kulwiswane nokukhathala. Isibonelo, ama-AKT inhibitors ahlanganiswa kumaphrothokholi okukhiqiza i-CAR-T, abonisa umsebenzi othuthukisiwe wokulwa nomdlavuza kumamodeli e-leukemia angaphambi kokwelashwa. Ngaphezu kwalokho, amaseli e-CAR-T aklanyelwe ukukhiqiza ama-cytokine avuselela amasosha omzimba, njenge-IL-18, abonisa ukulawulwa komdlavuza okuphakeme emzimbeni kanye nokwanda okuqhubekayo kwamaseli ezivivinyweni zemitholampilo zesigaba sokuqala.

 

Njengoba isidingo somhlaba wonke sokwelashwa kwe-CAR-T sikhula, lokhu kuthuthuka kuletha amandla okuguqula ukunakekelwa kweziguli, okwenza ukwelashwa okuphumelelayo kutholakale ngokushesha nangezinga elikhulu.